8 Recruiting Advanced Malignant Solid Neoplasm Phase 1 / Phase 2 Clinical Trials

Active phase 1 / phase 2 studies for advanced malignant solid neoplasm enrolling across the USA. Verify eligibility and contact site coordinators.

All Advanced Malignant Solid Neoplasm studies

Phase 1 / Phase 2 Studies for Advanced Malignant Solid Neoplasm

🔵 Active, Not Recruiting Phase1 / Phase2

Methoxyamine, Cisplatin, and Pemetrexed Disodium in Treating Patients With Advanced Solid Tumors or Mesothelioma That Cannot Be Removed by Surgery or Mesothelioma That Is Refractory to Pemetrexed Disodium and Cisplatin or Carboplatin

📍 City of Hope Comprehensive Cancer Center — Duarte, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Niraparib, Temozolomide and Atezolizumab in Treating Patients With Advanced Solid Tumors and Extensive-Stage Small Cell Lung Cancer With a Complete or Partial Response to Platinum-Based First-Line Chemotherapy

📍 UCLA / Jonsson Comprehensive Cancer Center — Los Angeles, California

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Avelumab, Utomilumab, Anti-OX40 Antibody PF-04518600, and Radiation Therapy in Treating Patients With Advanced Malignancies

📍 M D Anderson Cancer Center — Houston, Texas

View Study & Checklist ➔

🔵 Active, Not Recruiting Phase1 / Phase2

Testing the Addition of an Anti-cancer Drug, Copanlisib, to the Usual Immunotherapy (Nivolumab With or Without Ipilimumab) in Patients With Advanced Solid Cancers That Have Changes in the Following Genes: PIK3CA and PTEN

📍 Dana-Farber Cancer Institute — Boston, Massachusetts

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Phase I/II Randomized Study of NBTXR3 Activated by Abscopal or RadScopal Radiation in Combination With Immunotherapy (Anti-PD-1/L-1) for Patients With Advanced Solid Malignancies

📍 M D Anderson Cancer Center — Houston, Texas

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

📍 Yale University — New Haven, Connecticut

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Axatilimab in Combination With Retifanlimab and Paclitaxel for the Treatment of Patients With Advanced or Metastatic Solid Tumors

📍 OHSU Knight Cancer Institute — Portland, Oregon

View Study & Checklist ➔

🟢 Recruiting Phase1 / Phase2

Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

📍 UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care — Irvine, California

View Study & Checklist ➔